SETD2 and neoplasm: Tumors frequently adapt to hypoxia by preventing the degradation of hypoxia-induced transcription factor complexes (i.e., HIF1 and HIF2) resulting in their stabilization and subsequent transcription of genes that promote tumor survival, including proangiogenic cytokines (Giaccia et al., 2004; Keith et al., 2012).